CAR-T cell therapy combines cutting-edge genetic engineering with immunology to reprogram T cells into cancer-fighting weapons. With growing success in blood cancers, this therapy highlights the future of precision medicine and personalized cancer care, paving the way for broader clinical applications. https://www.xelleratherapeutics.com/services/custom-manufacturing-services/